# A Weight Loss Study in Overweight Men and Women

> **NCT00993421** · PHASE2 · TERMINATED · sponsor: **Eli Lilly and Company** · enrollment: 343 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** LY377604
- **DRUG:** Sibutramine
- **DRUG:** Metoprolol
- **DRUG:** Placebo sibutramine
- **DRUG:** Placebo Metoprolol
- **DRUG:** Placebo LY377604

## Key facts

- **NCT ID:** NCT00993421
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-10
- **Primary completion:** 2010-06
- **Final completion:** 2010-06
- **Target enrollment:** 343 (ACTUAL)
- **Why stopped:** Clinical trial terminated due to results from recent nonclinical studies
- **Last updated:** 2011-06-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00993421

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00993421, "A Weight Loss Study in Overweight Men and Women". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00993421. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*